Implanet SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013470168
EUR
0.17
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Implanet SA stock-summary
stock-summary
Implanet SA
Pharmaceuticals & Biotechnology
Implanet SA is a France-based company. It is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The Company's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws and anchors, among others. Its brands portfolio includes Spine System and Jazz. The Implanet Spine System aims to provide immobilization and stabilization of the spinal segments in skeletally mature patients as an adjunct to fusion of the thoracic, lumbar and sacral spine. The Implanet Jazz System, its flagship product, is an implant used to improve the treatment of spinal conditions requiring vertebral fusion.
Company Coordinates stock-summary
Company Details
Technopole Bordeaux Montesquieu, Allee Francois Magendie MARTILLAC None : 33650
stock-summary
Tel: 33 5 5799555533 5 57995555
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jean-Gerard Galvez
Chairman of the Board
Mr. Ludovic Lastennet
Chief Executive Officer, Director
Mr. Jan Egberts
Independent Director
Ms. Mary Shaughnessy
Independent Director
Ms. Paula Ness Speers
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 30 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-3.74

stock-summary
Return on Equity

342.96%

stock-summary
Price to Book

-21.68